(Q40703656)

22 September 2017

title

Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico (English)

1 reference

22 September 2017

1 reference

Lazcano-Ponce E

1

1 reference

22 September 2017

Rivera L

2

1 reference

22 September 2017

Arillo-Santillán E

3

1 reference

22 September 2017

Salmerón J

4

1 reference

22 September 2017

Hernández-Avila M

5

1 reference

22 September 2017

Muñoz N

6

1 reference

22 September 2017

publication date

1 May 2001

1 reference

Archives of Medical Research

22 September 2017

published in

1 reference

22 September 2017

volume

32

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

243-247

1 reference

Hepatitis B: global importance and need for control

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

Estimates of the worldwide incidence of 25 major cancers in 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

HPV vaccine treatment trials proliferate, diversify

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

Phase IIa safety and immunogenicity of a therapeutic vaccine, TA-GW, in persons with genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

Acceptance of hepatitis B vaccine among hospital workers

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

Acceptability of genital herpes immunization. The role of health beliefs and health behaviors.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

Vaccine characteristics and acceptability of HIV immunization among adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

Attitudes about human immunodeficiency virus immunization: the influence of health beliefs and vaccine characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900277-6

7 January 2021

10.1016/S0188-4409(01)00277-6

Identifiers

DOI

1 reference

22 September 2017

1 reference